US +1 (888) 690-5999( Toll-Free )
UK +44 8083 023308( Toll-Free )
Reports available on Market Reports World incorporate a comprehensive research statistics of all aspects of the market that offer you a thorough business intelligence. Gaining an in-depth predicative and competitive analysis of the market aids your business in dominating the market and that is what we aspire towards. Market Reports World provide you various industry-centric reports that aid your business in augmenting its growth. The reports we sell are integrated with market analysis data of the key players, leading market segments and latest market trends across the globe.
| Report Title | Published Date | Price |
|---|---|---|
PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets
No. of Pages: 265PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets Summary latest report, PI3K Signaling Pathway |
01-Jul-2018
|
2995
|
Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline
No. of Pages: 57Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline Summary latest report “Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline” is a comprehensive, |
14-Dec-2018
|
2995
|
Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape
No. of Pages: 99Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape Summary latest report “Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory |
03-Jan-2019
|
2995
|
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics
No. of Pages: 108Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics Summary latest report: “Biosimilars” provides an in-depth assessment |
01-Jan-2019
|
2995
|
Global Clinical Trials - Current Trends and Recent Advancement
No. of Pages: 65Global Clinical Trials - Current Trends and Recent Advancement Summary latest report, Global Clinical Trials - Current Trends and Recent Advancement, provides an in-depth assessment of |
01-Jan-2019
|
2995
|
Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players
No. of Pages: 93Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players Summary Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and |
12-Oct-2018
|
2995
|
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players
No. of Pages: 140The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players Summary GBI Research’s latest report, The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts |
04-May-2018
|
2995
|
Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018
No. of Pages: 104Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018 Summary GBI Research’s latest report: “Artificial Intelligence Technologies: Market Prospects - Featuring Expert |
30-Mar-2018
|
2995
|
Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies
No. of Pages: 106Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies Summary GBI Research’s latest report, Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, |
01-Feb-2018
|
2995
|
Current and Future Trends in Rx-to-OTC Switching with Insight from Key Industry Opinion Leaders
No. of Pages: 72Current and Future Trends in Rx-to-OTC Switching with Insight from Key Industry Opinion Leaders Summary Rx-to-OTC switching is the process in which a drug which has formerly |
05-Oct-2017
|
2995
|